About Mogens Gisselbaek, MD, MSc
Mogens Gisselbaek, MD, MSc is the founder of Gisselbaek Consulting: a physician executive, fractional CMO, Medical Director and senior medical consultant for biotech, medtech, specialty pharma, investors and boards across the Nordics, Europe and the UK.
He helps organisations access senior clinical and medical leadership at moments where development decisions define enterprise value. After more than two decades in global pharma, biotech and medtech, he founded Gisselbaek Consulting to provide senior-level ownership of strategy and execution without necessarily requiring a permanent full-time CMO or Medical Director hire.
Selected leadership experience
- Chief Medical Officer in an orthopaedic biotech.
- Senior Director in Global Clinical Drug Development at Novo Nordisk.
- Medical Director and Medical Affairs leader in international companies.
- Leadership of global clinical development programmes across Phase I-IV.
- Built and strengthened Medical Affairs organisations in multiple company contexts.
- Accountability for medical and scientific review in high-visibility, compliance-sensitive environments.
Where Mogens adds most value
Complex situations where medical, scientific, clinical, organisational and business considerations meet: building or transforming Medical Affairs; strengthening a clinical development path; translating data into a decision-ready programme; improving leadership capability; or providing an independent medical perspective for a board, investor or partner process.
Perspective on value creation
Different innovation models require different development logic. Internal innovation, external innovation, biotech financing, medtech evidence generation, investor due diligence and partnerships each require a different balance of risk, evidence, governance and execution. The objective is always the same: maximise enterprise value by making the development path credible, decision-ready and executable.
How I work
I am hands-on, collaborative and pragmatic. I work with executive teams, clinical teams, CROs, agencies and advisors, and take responsibility for making the decision in front of the organisation clearer and more executable. The focus is what matters for patients, regulators, payers, prescribers, investors and the company’s next value-inflection point.
Typical situations
- A biotech is preparing for first-in-human, proof of concept or the next financing round.
- A medtech company needs a stronger clinical evidence strategy.
- A specialty pharma company needs senior Medical Affairs capacity before launch or expansion.
- An investor or board needs independent medical and clinical due diligence.
- A company needs interim Medical Director or fractional CMO support while building the permanent organisation.
The senior medical expert you meet is the senior medical expert who does the work.
Let’s talk if you are building, scaling, financing or repositioning a biotech, medtech or specialty pharma company and need senior clinical or medical leadership.